Bovie Medical Corporation  

(Public, NYSEMKT:BVX)   Watch this stock  
Find more results for Ian J. McCarthy
3.19
-0.01 (-0.31%)
Apr 24 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 3.15 - 3.36
52 week 2.20 - 5.00
Open 3.25
Vol / Avg. 55,389.00/108,634.00
Mkt cap 72.32M
P/E     -
Div/yield     -
EPS -1.02
Shares 22.67M
Beta 0.45
Inst. own 16%
May 8, 2015
Q1 2015 Bovie Medical Corp Earnings Release - 9:30AM EDT - Add to calendar
May 8, 2015
Q1 2015 Bovie Medical Corp Earnings Call - 9:00AM EDT - Add to calendar
Feb 27, 2015
Q4 2014 Bovie Medical Corp Earnings Call
Feb 27, 2015
Q4 2014 Bovie Medical Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -69.51% -62.43%
Operating margin -24.01% -21.13%
EBITD margin - -17.97%
Return on average assets -74.18% -59.58%
Return on average equity -524.48% -177.05%
Employees 152 -
CDP Score - -

Address

4 Manhattanville Rd Ste 106
PURCHASE, NY 10577-2119
United States - Map
+1-727-3842323 (Phone)
+1-631-4215821 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bovie Medical Corporation is a maker of medical devices and supplies as well as the developer of J-Plasma, a unique, patented plasma-based surgical product. J-Plasma utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents during surgery. The Company sells its products to doctors� offices, surgical centers and hospitals worldwide, under its own well-respected brands and on a private label basis to distributors worldwide. It also leverages its expertise in the design, development and manufacture of electrosurgical equipment by producing equipment for large, well known medical device manufacturers through original equipment manufacturing (OEM) agreements.

Officers and directors

Andrew Makrides Esq. Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
J. Robert Saron President, Chief Sales and Marketing Officer, Director
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert L. Gershon Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Peter L. Donato Chief Financial Officer, Treasurer, Secretary
Age: 45
Bio & Compensation  - Reuters
Moshe Citronowicz Senior Vice President
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jack McCarthy Chief Commercialization Officer
Age: 48
Bio & Compensation  - Reuters
John Andres Independent Director
Age: 57
Bio & Compensation  - Reuters
Michael E. Geraghty Independent Director
Age: 67
Bio & Compensation  - Reuters
Ian D. Sheffield MBA Independent Director
Age: 37
Bio & Compensation  - Reuters
Lawrence J. Waldman CPA Independent Director
Age: 68
Bio & Compensation  - Reuters